BCAL Diagnostics (ASX:BDX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on BCAL Diagnostics.
RELATED STOCKHEAD STORIES
Health Check: Which biotech boards are at risk of a ‘second strike’?
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
National biotech summit shows off a wealth of healthcare and medical innovation
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
Rise and Shine: Everything you need to know before the ASX opens
From high-tech cancer fighters to AI-wielding crime busters, these are some of the most innovative firms on the ASX
Up close and personal with ASX tech and Biotech
ASX Health Winners March: A rebound? Aussie biotech sector is on the radar of Asian investors
Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again
Rise and Shine: Everything you need to know before the ASX opens
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: ASX200 makes it a hat-trick after Tech Sector triumph
